deferiprone has been researched along with Arteriosclerosis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, AJ | 1 |
| Vercellotti, GM | 1 |
| Menchaca, HJ | 1 |
| Bloch, PH | 1 |
| Michalek, VN | 1 |
| Marker, PH | 1 |
| Murar, J | 1 |
| Buchwald, H | 1 |
1 other study available for deferiprone and Arteriosclerosis
| Article | Year |
|---|---|
Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
Topics: Animals; Antioxidants; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholest | 1997 |